Our Expertise

Seattle Cancer Care Alliance physicians are from Fred Hutchinson Cancer Research Center and UW Medicine and experts in the field of myelodysplastic syndrome and provide comprehensive, leading-edge expertise in diagnosing and treating myelodysplastic syndromes. Our patients have access to doctors and researchers from UW Medicine and Fred Hutchinson Cancer Research Center, world-renowned for its pioneering work with blood disorders and bone-marrow transplantations.

The Hutchinson Center is home of the largest bone-marrow transplant program in the world. Dr. E. Donnall Thomas, who pioneered bone-marrow transplantation and developed the clinical transplant program at the Hutchinson Center, was awarded the 1990 Nobel Prize in medicine or physiology in 1990.

The goal of SCCA physician researchers is to build on these accomplishments and develop new lifesaving options for all patients with serious blood diseases. SCCA patients are already benefiting from new and innovative therapies, such as mini bone-marrow transplants, immunotherapy, cord-blood transplants, and other treatments. 

Over the years tens of thousands of patients diagnosed with multiple myeloma, lymphoma, leukemia, myelodysplastic syndrome and other malignant and non-malignant blood disorders have come to SCCA to

receive the latest treatments.

We offer compassionate support during and after your care and are committed to helping you understand your health and treatment options because you and your family are part of the care team, too.